Epigenetics, a relatively underappreciated field by those unfamiliar with its significance, holds profound implications for our overall health and well-being. Simply put, epigenetics explores how external factors, such as lifestyle and environmental influences, can alter gene expression without modifying the underlying DNA sequence. This emerging science is essential for understanding how certain diseases, including cancer, can develop and progress. One area of particular interest in epigenetics is how alcohol consumption affects gene expression and contributes to cancer risk. This article delves into the complex relationship between epigenetics, alcohol, cancer, and the role of environmental factors in shaping these processes.
Epigenetics and cancer: A complex interplay
Epigenetics refers to the study of changes in gene activity that do not involve alterations in the DNA sequence. These changes can be passed on through cell divisions and even across generations. Various environmental factors, such as drugs, diet, stress, and notably, alcohol, interact with the epigenome - the complete set of epigenetic modifications in our genetic material - altering how our genes function.
One of the key epigenetic mechanisms involved in cancer is DNA methylation. This process adds a methyl group to specific DNA regions, effectively turning off genes. In the context of cancer, tumour suppressor genes, which typically inhibit cancerous growth, can become silenced through abnormal methylation patterns, contributing to the disease's progression. Alcohol plays a pivotal role in these epigenetic changes, particularly through the production of its metabolic by-product, acetaldehyde, which has genotoxic and carcinogenic properties.
Alcohol, acetaldehyde, and cancer risk
Alcohol's toxicity stems from acetaldehyde, a product of alcohol metabolism. Acetaldehyde is highly reactive with DNA, creating DNA adducts, or chemical bonds that alter DNA's structure and function. These adducts interfere with essential cellular processes such as DNA repair and replication, leading to genetic mutations. Over time, this accumulation of damage can result in cancerous growths.
Moreover, alcohol consumption generates reactive oxygen species (ROS), which are harmful, oxygen-containing molecules that induce oxidative stress. ROS damage DNA by modifying its structure, causing mutations, and impairing normal cell functions. Studies have shown that alcohol-related ROS build-up contributes significantly to the development of hepatocellular carcinoma (HCC), a type of liver cancer. ROS also damage lipids and proteins, further aggravating cellular integrity and function.
The role of inflammation in alcohol-related cancer
Chronic alcohol consumption also leads to inflammation, one of the body's natural responses to injury or stress. However, long-term inflammation caused by alcohol disrupts healthy cell turnover and promotes cancer development. Alcohol's effect on the immune system impairs its ability to detect and eliminate potentially cancerous cells, leaving the body more vulnerable to tumour formation.
Alcohol-induced inflammation has been linked to several cancers, including those of the liver, colon, and oral cavity. The oral microbiome, for example, contains bacteria that metabolise alcohol into acetaldehyde. These bacteria, particularly Streptococcus and Neisseria mucosa, produce significant amounts of acetaldehyde, which contributes to the development of oral cancer (OC). Chronic alcohol use exacerbates poor oral health, increasing acetaldehyde levels in the mouth and promoting mutagenesis - an important factor in the onset of OC.
Alcohol, colorectal cancer and liver disease
Another well-documented link between alcohol and cancer involves colorectal cancer (CRC), one of the most common cancers globally. Alcohol increases the risk of CRC primarily through the action of acetaldehyde and ROS, which damage the DNA of cells in the colon and rectum. In addition, alcohol disrupts folate metabolism, a vital process for DNA repair and methylation. Lower folate levels, as a result of alcohol consumption, are associated with a higher risk of CRC.
Long-term alcohol use is also a significant risk factor for liver cancer, particularly hepatocellular carcinoma (HCC). Liver cancer can arise from a variety of alcohol-induced conditions, such as cirrhosis, alcoholic hepatitis, and fatty liver disease. Acetaldehyde and ROS again play crucial roles in this process, damaging liver cells and promoting cancerous changes. Research indicates that alcohol consumption is responsible for about 19% of liver cancer-related deaths, with the risk doubling for heavy drinkers.
Other cancer types linked to alcohol
Apart from liver, colorectal, and oral cancers, alcohol consumption has been implicated in the development of cancers of the oesophagus, breast, stomach, and pancreas. Each of these cancers exhibits a similar pattern: alcohol disrupts normal cellular processes through DNA damage, methylation changes, and inflammation, promoting cancer progression.
Oesophageal cancer, for instance, is exacerbated by alcohol's ability to impair DNA repair and alter gene expression, particularly in genes involved in cell cycle control. In breast cancer, alcohol disrupts the epigenetic regulation of tumour suppressor genes, allowing uncontrolled cell division and tumour growth. Meanwhile, stomach and pancreatic cancers are linked to alcohol's promotion of oxidative stress and chronic inflammation, creating an environment conducive to carcinogenesis.
Dietary influence on cancer and epigenetics
Diet plays an important role in cancer prevention and treatment, offering a modifiable factor that individuals can control. Certain dietary choices can either exacerbate or mitigate cancer risk. For instance, red and processed meats, particularly those high in nitrates and nitrites, have been shown to increase cancer risk by promoting the formation of free radicals. Similarly, high-glycaemic and fried foods may fuel cancer progression.
Conversely, a diet rich in folate (vitamin B9), found in grains and vegetables, supports proper DNA methylation and repair, reducing cancer risk. However, alcohol lowers folate levels and interferes with DNA repair processes, exacerbating cancer risk. Foods high in antioxidants, such as lycopene, resveratrol, and omega-3 fatty acids, help combat oxidative stress and inflammation, offering protective effects against cancer.
Epigenetic therapies: A new frontier in cancer treatment
The principles of epigenetics are paving the way for innovative cancer treatments. Unlike traditional therapies, epigenetic treatments aim to reverse abnormal gene expression by targeting the chemical modifications that regulate gene activity. These therapies include DNA methyltransferase (DNMT) inhibitors such as decitabine and azacitidine, which reverse abnormal methylation patterns. Other treatments, like histone deacetylase inhibitors (HDIs), show promise in treating cancers like lymphomas and multiple myeloma by altering how tightly DNA is packaged, thereby influencing gene expression.
Although epigenetic therapies are showing great promise, challenges remain in fully understanding how to maximise their effectiveness and minimise side effects. As the field continues to evolve, epigenetics may hold the key to more personalised and effective cancer treatments in the future.
Understanding the complex interaction between alcohol, cancer and epigenetics
The intricate relationship between alcohol consumption, epigenetics, and cancer underscores the importance of understanding how lifestyle choices affect our health. While moderate alcohol use has been linked to some health benefits, such as reduced risks of neurological disorders and cardiovascular diseases, its association with cancer risk cannot be ignored. Alcohol's role in promoting inflammation, DNA damage, and abnormal gene expression highlights the need for caution and moderation.
As research continues to unveil the complex interactions between the environment and our genes, it becomes increasingly clear that preventive measures, including a healthy diet and responsible alcohol consumption, are essential for reducing cancer risk. Furthermore, the development of epigenetic therapies offers hope for more targeted and effective cancer treatments, potentially revolutionizing how we approach oncology in the coming years.
Ultimately, the old Maltese saying saħħa meaning "health" serves as a reminder that even in celebration, we must prioritise our well-being. While alcohol may play a part in our cultural traditions, it is essential to remain mindful of its potential impact on our health, particularly in the context of cancer. Prevention remains the best cure, and understanding the role of epigenetics in cancer is a critical step toward protecting our future health.
Renald Blundell is a biochemist and biotechnologist with a special interest in Natural and Alternative Medicine. He is a professor at the Faculty of Medicine and Surgery, University of Malta
Maya Abela is currently a medical student at the University of Malta